Fig. 8
Expression analysis of CXCL12 and SOX17 in GC cell lines and clinical samples. A Western blot showed that CXCL12 had the highest expression in KATO III and MKN-45 cell lines, and SOX17 had the highest expression in HGC-27 and MKN-45 cell lines. B The results of immunofluorescence analysis were consistent with the results of western blot. C IHC analysis showed that the expression of CXCL12 and SOX17 in CT-detected EMVI-positive samples was significantly higher than that in CT-detected EMVI-negative samples. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001